Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study. - Test2 - elhamkhani - TriplyDB

Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study.

Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study.

http://www.wikidata.org/entity/Q37242084

about

The transcription factor MIST1 is a novel human gastric chief cell marker whose expression is lost in metaplasia, dysplasia, and carcinoma.Clinicopathological characteristics of human epidermal growth factor receptor 2-positive Barrett's adenocarcinoma.Barrett's Esophagus: A Comprehensive and Contemporary Review for Pathologists.The changing role of the pathologist in the management of Barrett's oesophagus.Non-adenomatous forms of gastro-oesophageal epithelial dysplasia: an under-recognised entity?Overdiagnosis of high-grade dysplasia in Barrett's esophagus: a multicenter, international study.[Barrett's esophagus. An update].[Intraepithelial neoplasia of Barrett's esophagus: prognosis of potential malignancy].Foveolar type dysplasia in Barrett esophagus

P2860

Q34087033-045D33C8-B3E0-4DD7-8F8C-8B98D5760B82 Q36410392-F37B1E0B-D6DC-4049-B096-84EB5280710D Q36803517-D566271E-EB71-472C-88E3-441F788A8398 Q38210245-1C6B79AC-6FD1-4827-B345-7E6878F27E9C Q38245405-692A2928-109D-42F8-AAC2-99E310BAED21 Q38353516-0BB92CA7-BA86-478A-AF4C-C75D54646BF8 Q53095026-29174D2A-6542-4F91-9808-9A19759B075F Q53278117-BA09C368-A394-47B8-9D16-B8109D688AA1 Q57742753-B8AE5156-847F-4314-AB60-083FC240B4AB

P2860

Nonadenomatous dysplasia in barrett esophagus: a clinical, pathologic, and DNA content flow cytometric study.

http://www.wikidata.org/entity/Q37242084

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on June 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Nonadenomatous dysplasia in ba ...... content flow cytometric study.

@en

Nonadenomatous dysplasia in ba ...... content flow cytometric study.

@nl

type

label

Nonadenomatous dysplasia in ba ...... content flow cytometric study.

@en

Nonadenomatous dysplasia in ba ...... content flow cytometric study.

@nl

prefLabel

Nonadenomatous dysplasia in ba ...... content flow cytometric study.

@en

Nonadenomatous dysplasia in ba ...... content flow cytometric study.

@nl

P1433

Q37242084-D64CFC13-3BE1-4050-9D7C-39CD4022B3B8

P1476

Q37242084-3E7F43A8-2B01-44B1-98BB-D21E4883B8C6

P2093

Q37242084-1F80DC3A-079F-4A9C-9100-6980564BED81

Q37242084-2984003C-8B41-4010-86D5-03D3F7DFCEF1

Q37242084-668F91F9-9B9B-4496-A55E-853A5E18FEF0

Q37242084-692FFE18-EA4C-4125-9AE0-DF9463CD5B9D

Q37242084-92EE96A7-AD2E-47B2-9485-0BB837B5E758

Q37242084-C61D1366-B814-42E9-9EAC-8D403EA38EF6

Q37242084-E41517CB-6A02-4A2E-B319-53CD97056312

P2860

Q37242084-027EADB5-3597-445C-A560-A2E54978E9DF

Q37242084-0829A3CB-066E-4353-BA1F-05875355699F

Q37242084-0C6CE85B-592A-428A-B29A-7CA975E58759

Q37242084-0EACAC24-10DB-49A4-A0D1-072995580AC7

Q37242084-33C01D88-08EA-477B-BAAF-8E9A5B0FF2A6

Q37242084-3E53B9E5-5910-47B3-81EC-996970699D73

Q37242084-3FC13707-BABE-4593-995D-C654B3AE6CD0

Q37242084-5F32BB96-3CBF-40C1-9949-F89DB41B21D4

Q37242084-681210C0-981F-4D28-A356-1A7E302DA468

Q37242084-7DBEC331-CB64-4FE8-88C7-7EAEE37A3A89

P304

Q37242084-C7B992C8-EF86-4484-8A21-35C091C0E764

P31

Q37242084-8DF6CFAE-1A86-4F5E-A7D4-40AAAABD7E16

P356

Q37242084-38AEAF9D-2593-402E-A852-A682EA1D496A

P407

Q37242084-DA7067AE-1CF3-48AC-B4A1-8D7ACE02BC7D

P433

Q37242084-8AB26EBC-C94E-4B9D-81E6-DB18D97BEBD5

P478

Q37242084-5CA9A359-18FA-4BAE-B04E-E315EA8FF546

P50

Q37242084-E57D01FF-5DAE-4214-92A4-0ED1A5A6BAE4

P577

Q37242084-B5B8D52B-13B2-41C7-A177-B3363BDB7341

P698

Q37242084-A345240D-8511-4FC4-A107-FF3DD0808649

P932

Q37242084-CE0A4A35-2E99-49FB-AA52-452D5DBA9BAE

P356

PAS.0B013E318198A1D4

P1433

The American Journal of Surgical Pathology

P1476

Nonadenomatous dysplasia in ba ...... content flow cytometric study.

@en

P2093

Brian J Reid

http://www.w3.org/2001/XMLSchema#string

Carissa A Sanchez

http://www.w3.org/2001/XMLSchema#string

Kumran Ayub

http://www.w3.org/2001/XMLSchema#string

Peter S Rabinovitch

http://www.w3.org/2001/XMLSchema#string

Rachel L Rucker-Schmidt

http://www.w3.org/2001/XMLSchema#string

Robert D Odze

http://www.w3.org/2001/XMLSchema#string

Xiahong Li

http://www.w3.org/2001/XMLSchema#string

P2860

NSAIDs modulate CDKN2A, TP53, and DNA content risk for progression to esophageal adenocarcinoma

Evolution of neoplastic cell lineages in Barrett oesophagus

Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation.

Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.

Selectively advantageous mutations and hitchhikers in neoplasms: p16 lesions are selected in Barrett's esophagus.

The combination of genetic instability and clonal expansion predicts progression to esophageal adenocarcinoma.

Genetic clonal diversity predicts progression to esophageal adenocarcinoma.

Diagnosis and grading of dysplasia in Barrett's oesophagus.

Updated guidelines 2008 for the diagnosis, surveillance and therapy of Barrett's esophagus.

Predictors of progression in Barrett's esophagus III: baseline flow cytometric variables.

P304

886-893

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/PAS.0B013E318198A1D4

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

33

http://www.w3.org/2001/XMLSchema#string

P50

Patricia L Blount

P577

2009-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19194279

http://www.w3.org/2001/XMLSchema#string

P932

2702161

http://www.w3.org/2001/XMLSchema#string